EirGenix (6589) - Total Liabilities

Latest as of June 2025: NT$1.94 Billion TWD ≈ $61.13 Million USD

Based on the latest financial reports, EirGenix (6589) has total liabilities worth NT$1.94 Billion TWD (≈ $61.13 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore EirGenix (6589) cash conversion ratio to assess how effectively this company generates cash.

EirGenix - Total Liabilities Trend (2017–2024)

This chart illustrates how EirGenix's total liabilities have evolved over time, based on quarterly financial data. Check 6589 financial resilience to evaluate the company's liquid asset resilience ratio.

EirGenix Competitors by Total Liabilities

The table below lists competitors of EirGenix ranked by their total liabilities.

Company	Country	Total Liabilities
iQIYI Inc F:IQ8	Germany	€32.45 Billion
Sarkuysan Elektrolitik Bakir Sanayi ve Ticaret AS IS:SARKY	Turkey	TL13.79 Billion
Changchun Zhiyuan New Energy Equipment Co. Ltd SHE:300985	China	CN¥1.50 Billion
Girisim Elektrik Taahhut Ticaret & Sanayi AS IS:GESAN	Turkey	TL9.62 Billion
APG SGA SA SW:APGN	Switzerland	CHF93.01 Million
ECN Capital Corp TO:ECN	Canada	CA$757.90 Million
Zhewen Pictures Group Co Ltd SHG:601599	China	CN¥1.99 Billion
Stingray Group Inc TO:RAY-A	Canada	CA$866.47 Million

Liability Composition Analysis (2017–2024)

This chart breaks down EirGenix's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 6589 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.86	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EirGenix's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EirGenix (2017–2024)

The table below shows the annual total liabilities of EirGenix from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$1.62 Billion ≈ $50.98 Million	+41.31%
2023-12-31	NT$1.15 Billion ≈ $36.08 Million	-1.65%
2022-12-31	NT$1.16 Billion ≈ $36.68 Million	+15.03%
2021-12-31	NT$1.01 Billion ≈ $31.89 Million	-47.55%
2020-12-31	NT$1.93 Billion ≈ $60.79 Million	+1558.06%
2019-12-31	NT$116.38 Million ≈ $3.67 Million	-86.89%
2018-12-31	NT$887.57 Million ≈ $27.96 Million	+61.21%
2017-12-31	NT$550.56 Million ≈ $17.35 Million	--

About EirGenix

TWO:6589 Taiwan Biotechnology

Market Cap

$632.48 Million

NT$20.08 Billion TWD

Market Cap Rank

#11429 Global

#394 in Taiwan

Share Price

NT$66.40

Change (1 day)

+0.45%

52-Week Range

NT$59.60 - NT$66.40

All Time High

NT$188.50